Inner Mongolia Yili Industrial Group has filed a patent for a composition containing Bifidobacterium lactis and human milk oligosaccharides (HMOs) to enhance resistance to Staphylococcus aureus infection, improve innate immunity, and anti-aging effects. The composition can be added to health and healthcare foods. GlobalData’s report on Inner Mongolia Yili Industrial Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Inner Mongolia Yili Industrial Group, Lactobacilli-based drug compositions was a key innovation area identified from patents. Inner Mongolia Yili Industrial Group's grant share as of January 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Probiotic composition with human milk oligosaccharides
See Also:
The patent application US20240000868A1 discloses a composition comprising Bifidobacterium lactis and human milk oligosaccharides (HMOs). The composition includes specific strains of Bifidobacterium lactis and a combination of HMOs, such as 2'-fucosyllactose, 3'-fucosyllactose, lactose-N-tetraose, 3'-sialyllactose, and 6'-sialyllactose, in specific weight ratios. The ratio of Bifidobacterium lactis to HMOs is also defined, along with the use of this composition in enhancing resistance to Staphylococcus aureus infection, improving innate immunity, and anti-aging.
Furthermore, the patent application describes the use of the composition in the manufacture of food products or medicaments, particularly for enhancing resistance to Staphylococcus aureus infection. The application details the specific amounts of Bifidobacterium lactis and HMOs to be used in daily intake for optimal effectiveness. Additionally, the method for administering the composition to enhance resistance to Staphylococcus aureus infection, improve innate immunity, and combat aging is outlined, emphasizing the potential benefits in preventing various infections and health conditions caused by Staphylococcus aureus. The application also highlights the use of the composition in various forms of food products, including infant formula powder, to deliver the desired health benefits effectively.
To know more about GlobalData’s detailed insights on Inner Mongolia Yili Industrial Group, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
